Nanoform Finland Oyj

€0.70As of Sun 8 Nov 2026, 12:00 UTC
HEL:NANOFHHealthcare
Country Finland
PE (Fwd) •••
TSR 6Y CAGR (24.72%)
Div yield —
ROE (32.12%)
Biotechnology
Beta (5Y) 0.90
PE TTM —
TSR TTM (38.36%)
Mkt cap €59.94M
ROIC (20.89%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€0.85
21.58%
(15.51%)
Hold 11|1|11|3|8
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.01
0.01
0.01
0.02
14.80%
3.90%
4.02%
15.60%
Revenue€M
5.409
5.610
5.763
6.018
2.33%
5.83%
6.41%
8.99%
Peers (US$67.31M)
Cap (US$)
PE
162.4M
—
67.46M
—
Capital
TTM
5Y
10Y
Leveragex
1.400
0.195
0.196
EBIT/Intx
0.261
0.529
0.667
Own earn%
140.70
42.52
43.10
Sh yield%
28.09
40.77
40.90
Owners
Insiders/Inst%
0.94
48.41
Short interest%
4.44
SBC / revenue%
0.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
15–23
$1 testx
0.3
Incr. ROIC%
−2